[Clinical Observation of Recombinant Bovine Basic Fibroblast Growth Factor as an Adjuvant Therapy for Patients with Atrophic Acne Scar].


Journal

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
ISSN: 1000-503X
Titre abrégé: Zhongguo Yi Xue Ke Xue Yuan Xue Bao
Pays: China
ID NLM: 8006230

Informations de publication

Date de publication:
Apr 2022
Historique:
entrez: 11 5 2022
pubmed: 12 5 2022
medline: 14 5 2022
Statut: ppublish

Résumé

Objective To study the influence of recombinant bovine basic fibroblast growth factor as an adjuvant therapy on scar alleviation and inflammatory cytokines in patients with atrophic acne scar. Methods The random number table was employed to randomly assign 120 patients with atrophic acne scar into a test group and a control group.Both groups of patients were treated with CO

Identifiants

pubmed: 35538754
doi: 10.3881/j.issn.1000-503X.13708
doi:

Substances chimiques

Tumor Necrosis Factor-alpha 0
Fibroblast Growth Factor 2 103107-01-3
Carbon Dioxide 142M471B3J

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

208-212

Auteurs

Hong-Xia DU (HX)

Department of Dermatology, Xinyang Central Hospital,Xinyang,Henan 464000,China.

Yuan-Yuan Hu (YY)

Department of Medical Cosmetology,Xinyang Central Hospital,Xinyang,Henan 464000,China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH